Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages

References

Page 1

	Year	Citations
Nextstrain: real-time tracking of pathogen evolution James Hadfield, Colin Megill, Sidney M. Bell, Bioinformatics	2018	3.3K
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody Dora Pinto, Young‐Jun Park, Martina Beltramello, Nature Vaccine TargetImmunologyAntibody EngineeringMedicineCovid-19	2020	2.1K
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies Christopher O. Barnes, Claudia A. Jette, Morgan E. Abernathy, Nature	2020	1.8K
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization Delphine Planas, Nell Saunders, Piet Maes, Nature Vaccine TargetImmunologyAntibody ScreeningAntibody EngineeringImmunotherapy	2021	1.6K
Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool Áine O’Toole, Emily Scher, Anthony Underwood, Virus Evolution	2021	1.2K
Potently neutralizing and protective human antibodies against SARS-CoV-2 Seth J. Zost, Pavlo Gilchuk, James Brett Case, Nature	2020	1.2K
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies Laura A. VanBlargan, John M. Errico, Peter Halfmann, Nature Medicine VaccinationTherapeutic Monoclonal AntibodiesImmunologyViral PathogenesisAntiviral Response	2022	758
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum Aekkachai Tuekprakhon, Rungtiwa Nutalai, Aiste Dijokaite-Guraliuc, Cell	2022	750
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum Chang Liu, Helen M. Ginn, Wanwisa Dejnirattisai, Cell Viral DiagnosticsVaccine SeraImmunologyViral PathogenesisUnited Kingdom	2021	744
Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa Houriiyah Tegally, Monika Moir, Josie Everatt, Nature Medicine	2022	686

Page 1